Loading...
Loading...
India's moxifloxacin imports from SOUTH AFRICA total $602 across 1 shipments from 1 foreign suppliers. RBC PHARMACEUTICALS (PTY) LIMITED leads with $602 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include MSN LABORATORIES PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for moxifloxacin — a concentrated sourcing relationship with select suppliers from SOUTH AFRICA.

RBC PHARMACEUTICALS (PTY) LIMITED is the leading Moxifloxacin supplier from SOUTH AFRICA to India, with import value of $602 across 1 shipments. The top 5 suppliers — RBC PHARMACEUTICALS (PTY) LIMITED — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | RBC PHARMACEUTICALS (PTY) LIMITED | $602 | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MSN LABORATORIES PRIVATE LIMITED | $602 | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Moxifloxacin suppliers from SOUTH AFRICA to India include RBC PHARMACEUTICALS (PTY) LIMITED. The leading supplier is RBC PHARMACEUTICALS (PTY) LIMITED with import value of $602 USD across 1 shipments. India imported Moxifloxacin worth $602 USD from SOUTH AFRICA in total across 1 shipments.
India imported Moxifloxacin worth $602 USD from SOUTH AFRICA across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Moxifloxacin sourced from SOUTH AFRICA include MSN LABORATORIES PRIVATE LIMITED. The largest buyer is MSN LABORATORIES PRIVATE LIMITED with $602 in imports across 1 shipments.
The total value of Moxifloxacin imports from SOUTH AFRICA to India is $602 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists